Annual Drug Patent Expirations for TYVASO
Tyvaso is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are eleven patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for TYVASO.
This drug has thirty-five patent family members in nine countries.
The generic ingredient in TYVASO is treprostinil. One supplier is listed for this compound. Additional details are available on the treprostinil profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
